Drug profile · INN
pegfilgrastim-cbqv
UDENYCA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pegfilgrastim-cbqv (UDENYCA) is an FDA-listed pharmaceutical active ingredient. Associated with Coherus Oncology. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN pegfilgrastim-cbqv
Brand UDENYCA
Route INJECTION
Formulation INJECTABLE
Originator Coherus Oncology
Frequently asked questions
What is pegfilgrastim-cbqv?
pegfilgrastim-cbqv (UDENYCA) is an FDA-listed pharmaceutical active ingredient. Associated with Coherus Oncology. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pegfilgrastim-cbqv?
UDENYCA is a marketed brand name for pegfilgrastim-cbqv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegfilgrastim-cbqv?
pegfilgrastim-cbqv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.